Sapan Ghai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFiske Regulatory News (FKE)

Share Price Information for Fiske (FKE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.50
Bid: 70.00
Ask: 85.00
Change: 0.00 (0.00%)
Spread: 15.00 (21.429%)
Open: 77.50
High: 77.50
Low: 77.50
Prev. Close: 77.50
FKE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

13 Feb 2014 14:00

RNS Number : 0291A
Fiske PLC
13 February 2014
 



 

13 February 2014

 

 

Fiske Plc

('Fiske' or 'the Company')

 

Interim Results

 

Fiske Plc (the 'Company') announces its interim results for the six months ended 30 November 2013. In accordance with rule 26 of the AIM Rules for Companies this information is also available, under the Investors section, at the Company's website, http://www.fiskeplc.com .

 

For further information please contact:

 

• Salmaan Khawaja/David Hignell Grant Thornton UK LLP (Nominated Adviser)

(tel: 020 7383 5100)

 

• Gerard Luchini, Fiske Plc - Compliance Officer

(tel: 020 7448 4700)

 

 

 

 

 

Chairman's Statement

 

The half year under review has resulted in profits on ordinary activities after tax of £202,000. This is an improvement when set against £175,000 in the whole of last year and a break even position in the first half to November 2012. The additional net other comprehensive income of £92,000 reflects a revaluation, after a deferred tax provision, of our holding of 3,618 Euroclear shares. A recent share buy back by that company included purchases at €750 per share, still a significant discount to book asset value, but a more realistic benchmark for valuation purposes than that we have adopted. We remain confident of the long term value of this major investment.

 

In my statement last August I reflected on the buoyancy of the main equity markets and the questionable expectations of future corporate profits. That situation remains, but as in August the timing of any change remains uncertain. The withdrawal of "Quantitative Easing" in the US has commenced in a measured and gradual process and, as yet, the market reaction has been muted, partially influenced by the promise to keep interest rates at the current, and historically unheard of, levels for longer than previously anticipated. In our view market levels are not supported by fundamentals but mainly by liquidity. Not only is the level of US corporate profitability at an all-time high, the amount of "non recurring" items excluded from that figure is equally at an unusually inflated level. As a result we remain cautious.

 

With respect to our prospects for the second half of the year we do not make forecasts. However we will pay a first interim dividend of 0.35p per share, a modest increase on last year's level. The shares will be marked ex-dividend on the 19 February 2014 and the record date will be 21 February 2014.

 

The Board has always been conscious of the need for succession planning and in September 2012 we appointed James Harrison to be Chief Operating Officer. It is now intended that at our Annual General Meeting this year he will succeed me as Chief Executive. I will remain as Executive Chairman and will continue to work full time and in particular will remain as Investment Director.

 

It is also the decision of the Board to invite my son, Alexander Fiske-Harrison, to join the Board as a non-executive director in April of this year.

 

Stephen Cockburn who has served as a director of Fiske PLC, and prior to that of Fiske and Co Ltd since 1998, will be retiring at our next Annual General Meeting. Stephen has had a distinguished career in the City of London for over 50 years and as a Director of Fiske has offered us wise and helpful advice and we are very grateful for his services.

 

 

C F Harrison Chairman

13 February 2014

 

Consolidated Statement of Comprehensive Income

for the six months ended 30 November 2013

 

 

 

Six months ended

30 November 2013

Unaudited

Six months ended

30 November 2012

Unaudited

Year ended

31 May 2013

Audited

£'000

£'000

£'000

Fee and commission income

2,061

1,779

3,950

Fee and commission expenses

(532)

(463)

(1,075)

Net fee and commission income

1,529

1,316

2,875

Other income

102

109

176

Total revenue

1,631

1,425

3,051

Profit on investments held for trading

3

54

82

Operating expenses

(1,472)

(1,511)

(2,958)

Operating profit/(loss)

162

(32)

175

Investment revenue

66

26

34

Finance income

12

11

24

Finance costs

(1)

-

(1)

Profit on ordinary activities before taxation

239

5

232

Taxation

(37)

(3)

(57)

Profit on ordinary activities after taxation

202

2

175

Other comprehensive income/(expense)

Movement in unrealised appreciation of investments

115

1

488

Deferred tax on movement in unrealised appreciation of investments

 

(23)

 

-

 

(60)

Net other comprehensive income

92

1

428

Total comprehensive income for the period/year attributable to equity shareholders

 

294

 

3

 

603

Earnings per ordinary share (pence), excluding other comprehensive income

Basic

2.4p

0.0p

2.1p

Diluted

2.4p

0.0p

2.1p

 

All results are from continuing operations and are attributable to equity shareholders of the parent company.

Consolidated Statement of Changes in Equity

 

 

 

 

Share Capital

Share Premium

Revaluation Reserve

Retained Earnings

Total Equity

£'000

£'000

£'000

£'000

£'000

Balance at 1 December 2012

2,115

1,222

775

207

4,319

Profit on ordinary activities after taxation

-

-

-

173

173

Other comprehensive income

-

-

427

-

427

Total comprehensive income for period

-

-

427

173

600

Dividends paid

-

-

-

(21)

(21)

Balance at 31 May 2013

2,115

1,222

1,202

359

4,898

Profit on ordinary activities after taxation

-

-

-

202

202

Other comprehensive income

-

-

92

-

92

Total comprehensive income for period

-

-

92

202

294

Dividends paid

-

-

-

(21)

(21)

Balance at 30 November 2013

2,115

1,222

1,294

540

5,171

 

Consolidated Statement of Financial Position

30 November 2013

 

 

 

As at

30 November 2013

Unaudited

As at

30 November 2012

Unaudited

As at

31 May 2013

Audited

£'000

£'000

£'000

Non-current assets

Goodwill

395

395

395

Property, plant and equipment

41

53

38

Available-for-sale investments

2,411

1,225

2,296

Total non-current assets

2,847

1,673

2,729

Current assets

Trade and other receivables

12,080

4,492

12,514

Investments held for trading

282

201

35

Cash and cash equivalents

3,395

3,278

2,731

Total current assets

15,757

7,971

15,280

Current liabilities

Trade and other payables

13,033

5,074

12,772

Current tax liabilities

90

24

52

Total current liabilities

13,123

5,098

12,824

Net current assets

2,634

2,873

2,456

Non-current liabilities

Deferred tax liabilities

310

227

287

Total non-current liabilities

310

227

287

Net assets

5,171

4,319

4,898

Equity

Share capital

2,115

2,115

2,115

Share premium

1,222

1,222

1,222

Revaluation reserve

1,294

775

1,202

Retained earnings

540

207

359

Shareholders' equity

5,171

4,319

4,898

 

Consolidated Cash Flow Statement

For the six months ended 30 November 2013

 

 

 

Six months ended

30 November 2013

Unaudited

Six months ended

30 November 2012

Unaudited

Year ended

31 May 2013

Audited

£'000

£'000

£'000

Operating profit/(loss)

162

(32)

175

Depreciation of property plant and equipment

13

19

39

(Increase)/decrease in investments held for trading

(247)

50

216

Decrease/(increase) in receivables

434

1,289

(6,733)

Increase/(decrease) in payables

263

(1,200)

6,498

Cash generated from operations

625

126

195

Tax paid

(1)

-

(26)

Net cash generated from operating activities

624

126

169

Investing activities

Interest received

12

11

24

Investment income received

66

26

34

Interest paid

(1)

-

(1)

Purchases of available-for-sale investments

-

-

(585)

Purchases of property, plant and equipment

(16)

(36)

(40)

Net cash generated from/(used in) investing activities

61

1

(568)

Financing activities

Dividends paid

(21)

(85)

(106)

Net cash used in financing activities

(21)

(85)

(106)

Net increase/(decrease) in cash and cash equivalents

664

42

(505)

Cash and cash equivalents at beginning of period

2,731

3,236

3,236

Cash and cash equivalents at end of period/year

3,395

3,278

2,731

 

 

Notes to the Interim Financial Statements

1. Basis of preparation

The financial information contained in this half-yearly financial report does not constitute statutory accounts as defined in section 434 of the Companies Act 2006.

The figures and financial information for the period ended 31 May 2013 are extracted from the latest published audited financial statements of the Group and do not constitute the statutory financial statements for that period. The audited financial statements for the period ended 31 May 2013 have been filed with the Registrar of Companies. The report of the independent auditors on those financial statements contained no qualification or statement under section 498(2) or section 498(3) of the Companies Act 2006.

The condensed set of financial statements has been prepared using accounting policies consistent with International Financial Reporting Standards (IFRSs) as adopted by the European Union. The financial information has been prepared under the historical cost convention, except for the revaluation of certain financial instruments. The same accounting policies, presentation and methods of computation are followed in these condensed set of financial statements as applied in the Group's latest, and intends to use in preparing its next, annual audited financial statements. While the financial figures included in this half-yearly report have been computed in accordance with IFRSs applicable to interim periods, this half-yearly report does not contain sufficient information to constitute an interim financial report as that term is defined in IAS 34.

The directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. Thus they continue to adopt the going concern basis of accounting in preparing this half-yearly financial report.

2. Taxation

The tax charge for the six months to 30 November 2013 reflects all the necessary provisions for current tax, taking into account the availability of losses brought forward, and movements in deferred tax. In arriving at the effective tax rate account has been taken of the change in the rate of tax charged and the disallowance of the cost of share-based payments charged to the consolidated statement of comprehensive income.

3. Dividends paid

Dividends paid of £21,000 (2012 - £85,000) refer to the second interim dividend paid for the preceding year.

The Interim dividend of 0.35p will be paid on 21 March 2014 to shareholders on the register on 21 February 2014. The shares will be marked ex-dividend on 19 February 2014.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IR LLFFVFRIVLIS
Date   Source Headline
15th Apr 20244:27 pmRNSDirector Dealing
6th Mar 202411:51 amRNSDirector Dealing
22nd Feb 20241:21 pmRNSDirector Dealing
19th Feb 20244:38 pmRNSDirector Dealing
16th Feb 20242:47 pmRNSDirector Dealing
16th Feb 20247:00 amRNSInterim results
8th Dec 20234:56 pmRNSDirector Dealing
28th Nov 20233:38 pmRNSDirector Dealing
23rd Nov 202312:52 pmRNSResult of AGM and Confirmation of Board Changes
30th Oct 20233:42 pmRNSDirector Dealing
24th Oct 20237:00 amRNSFinal Results, Annual Report and Notice of AGM
22nd Aug 20231:19 pmRNSDirector dealing
6th Jul 20237:00 amRNSDirector Dealing
31st May 20233:27 pmRNSDirector Dealing
4th Apr 202312:38 pmRNSDirector Dealing
3rd Apr 202310:55 amRNSDirector Dealing
3rd Apr 20237:00 amRNSAcquisition of Client Book
2nd Mar 20237:00 amRNSInterim results
29th Nov 20221:58 pmRNSDirector Dealings
24th Nov 20225:31 pmRNSResult of AGM
20th Oct 20227:00 amRNSFinal Results, Annual Report and Notice of AGM
18th Aug 20229:30 amRNSHolding(s) in Company
17th Jun 20224:13 pmRNSDirector Dealing
1st Mar 20227:00 amRNSHalf-year Report
17th Dec 20214:47 pmRNSDirector Dealing
10th Dec 20217:00 amRNSChange to Accounting Year End
30th Nov 20217:00 amRNSChange of Registered Office
25th Oct 202110:56 amRNSResult of AGM
30th Sep 202111:23 amRNSTotal Voting Rights
29th Sep 20215:29 pmRNSDirector Dealing
17th Sep 20211:08 pmRNSDirector Shareholding & Director Dealing
17th Sep 20219:58 amRNSExercise of Share Options and Issue of Equity
14th Sep 20219:44 amRNSFinal Results, Annual Report and Notice of AGM
5th Jul 202112:56 pmRNSHolding(s) in Company
28th May 20214:21 pmRNSDirector Dealings and Director Shareholding Update
20th Apr 20217:00 amRNSDirector Shareholding Disclosure
19th Feb 20217:00 amRNSInterim Results
8th Feb 20215:28 pmRNSForm 8.3 - Marston's PLC
23rd Dec 20202:46 pmRNSResult of AGM
3rd Dec 202010:01 amRNSDirector Dealing
30th Nov 202012:20 pmRNSIssue of Equity
30th Nov 20207:00 amRNSFinal Results, Posting of Report and Notice of AGM
16th Nov 20207:30 amRNSSale of Euroclear shares
12th Nov 202011:31 amRNSSale of Euroclear shares
22nd Sep 20202:41 pmRNSForm 8.3 - Deltic Energy Plc
27th Jul 20203:54 pmRNSForm 8.3 - Deltic Energy Plc
16th Jul 20207:00 amRNSDirector Retirement
8th Apr 20207:00 amRNSCovid-19 and Trading Update
10th Mar 20209:57 amRNSDirector Dealing
26th Feb 20207:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.